Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
An index fund passively tracks a market index, while a mutual fund is often actively managed to beat benchmarks, affecting fees and risk.
13,023 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A focused look at a large institutional bet on Indivior, the logic behind the $143 million investment, and how such m...
A seasoned fund trimmed a big winner after a meteoric run. This article breaks down the why behind the move, the numb...
A recent SEC filing details Helix Partners exiting its Cinemark stake. This article breaks down what that exit means ...
A mid‑sized fund just boosted its stake in ServiceTitan after a sharp share drop. This article unpacks what the move ...
A major move by hedge fund incline global to liquidate its Maplebear stake prompts a closer look at CART stock. Read ...
Institutional funds often reveal conviction through large stake increases. This article explains the implications whe...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
A major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
A major fund recently disclosed a sizable sale of an AI marketing stock, a move that coincides with a 37% surge in th...
A hedge fund made a sizable Ultragenyx purchase as the stock slipped about 30% over the prior year. This article brea...